Philip Tsai is Chief Technology Officer of Immunome Inc.. Currently has a direct ownership of 33,300 shares of IMNM, which is worth approximately $241,425. The most recent transaction as insider was on Mar 24, 2025, when has been sold 12,300 shares (Common Stock) at a price of $8.42 per share, resulting in proceeds of $103,566. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.3K
58.57% 3M change
n/a 12M change
Total Value Held $241,425

Philip Tsai Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2025
BUY
Open market or private purchase
$103,566 $8.42 p/Share
12,300 Added 26.97%
33,300 Common Stock
Nov 21 2024
BUY
Open market or private purchase
$198,030 $9.43 p/Share
21,000 Added 50.0%
21,000 Common Stock
PT

Philip Tsai

Chief Technology Officer
Bothell, WA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM